A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolism

This publication has 23 references indexed in Scilit:

• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• BOLUS ALTEPLASE
  The Lancet, 1989
• Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1989
• RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
  The Lancet, 1988
• ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR
  The Lancet, 1986
• Tissue-Type Plasminogen Activator
  Drugs, 1986
• A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.
  Circulation, 1985
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
  Nature, 1983